28.42

7.33% 1.94

After Hours: 28.42

Alamar Biosciences Inc (ALMR)

Overview News Price History Discussions Forecast

Alamar Biosciences Inc stock is traded at $28.42, with a volume of 246.94K. It is up +7.33% in the last 24 hours and up +32.12% over the past month. Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.

Previous Close:

$26.48

Open:

$26.48

24h Volume:

246.94K

Relative Volume:

0.88

Market Cap:

$1.97B

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+9.56%

1M Performance:

+32.12%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$26.01

$28.49

1-Week Range:

$24.26

$28.49

52-Week Range:

$18.84

$28.68

Alamar Biosciences Inc Stock (ALMR) Company Profile

Name

Alamar Biosciences Inc

Sector

Healthcare (1096)

Industry

Medical Devices (140)

Phone

510-626-9888

Address

47071 BAYSIDE PARKWAY, FREMONT

Employee

Twitter

Next Earnings Date

2026-08-14

Latest SEC Filings

ALMR's Discussions on Twitter

Compare ALMR vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ALMR Alamar Biosciences Inc	28.42	1.97B	0	0	0	0.00
ABT Abbott Laboratories	93.93	163.61B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	329.78	126.42B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	83.87	107.36B	36.36B	4.84B	5.43B	3.7212
BSX Boston Scientific Corp	44.77	66.54B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	92.21	53.09B	6.30B	1.07B	1.09B	1.8406

Alamar Biosciences Inc Stock (ALMR) Latest News

07:37 AM

Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer's Biomarker Profiling - riauone.com

07:37 AM

Jul 10, 2026

AAIC 2026 逾 140 份学术报告均采用 Alamar Biosciences NULISA 数据，彰显阿尔茨海默病血液生物标志物分析领域的进展 - GlobeNewswire Inc.

Jul 10, 2026

Alamar’s platform to feature in 140+ presentations at AAIC - Investing.com India

Jul 10, 2026

Alamar Biosciences to Present NULISA Alzheimer’s Data in More Than 140 AAIC Posters and Sessions - Quiver Quantitative

Jul 10, 2026

New blood tests for Alzheimer’s take center stage at AAIC 2026 - Stock Titan

Jul 10, 2026

Jul 07, 2026

Form 13D/A Alamar Biosciences For: 7 July By Investing.com - Investing.com Nigeria

Jul 07, 2026

Sands Capital reports 6.1% Alamar Biosciences (ALMR) stake and board change - Stock Titan

Jul 07, 2026

Price to book forward of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView

Jul 07, 2026

Alamar Biosciences Launches First Commercial Blood-Based eMTBR-Tau Assay for Alzheimer’s Disease - Quiver Quantitative

Jul 07, 2026

Alamar puts Alzheimer’s tau tangle test into blood panels - Stock Titan

Jul 07, 2026

Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research - wahanariau.com

Jul 07, 2026

Jul 06, 2026

Price to sales forward of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView

Jul 06, 2026

Jul 02, 2026